Page last updated: 2024-11-06

2-naphthylamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

naphthalene-2-carboxamide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

naphthalene-2-carboxamide : A naphthalenecarboxamide resulting from the formal condensation of the carboxy group of 2-naphthoic acid with ammonia. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID75245
CHEMBL ID154085
CHEBI ID88317
SCHEMBL ID546633
MeSH IDM0196586

Synonyms (43)

Synonym
nsc171209
2243-82-5
2-naphthalenecarboxamide
nsc-171209
TIMTEC1_000199
NCGC00175368-01
2-naphthylamide
HMS1534J01
CHEMBL154085 ,
naphthalene-2-carboxylic acid amide
chebi:88317 ,
BRD-K98106866-001-01-4
AKOS003827412
naphthalene-2-carboxamide
2-naphthamide
A816209
einecs 218-820-4
beta-naphthylamide
nsc 171209
FT-0613115
S10612
bdbm50440132
2-naphthalene carboxamide
naphthalene-2-amide
2-carbamoylnaphthalene
SCHEMBL546633
.beta.-naphthamid
2-naphthamide #
.beta.-naphthamide
isonaphthoic amide
beta-naphthamide
(2-naphthalenylcarbonyl)-imidogen
mfcd00016812
Z33546615
CS-W021732
DS-5183
2naphthylamide
DTXSID00876686
Q27160181
SY109446
sodiump-chlorobenzoate
SB66849
EN300-212934
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
naphthalenecarboxamideAny member of the class of naphthalenes in which the naphthalene ring is directly attached to the carbonyl carbon of a carboxamide group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LysR family transcriptional regulator Pseudomonas aeruginosaKd1.30000.21000.93671.8000AID770029; AID770032
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID770026Antagonist activity at Pseudomonas aeruginosa PA14 PqsR expressed in Eschericia coli DH5-alpha assessed as inhibition of PQS-induced protein activation at 100 uM by beta-galactosidase reporter gene assay relative to control2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Discovery and biophysical characterization of 2-amino-oxadiazoles as novel antagonists of PqsR, an important regulator of Pseudomonas aeruginosa virulence.
AID770031Competitive binding affinity to Pseudomonas aeruginosa PA14 biotinylated His6SUMO-tagged PqsR expressed in Eschericia coli BL21 (DE3) at 0.11 to 9 uM by surface plasmon resonance spectroscopic analysis in presence of PQS2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Discovery and biophysical characterization of 2-amino-oxadiazoles as novel antagonists of PqsR, an important regulator of Pseudomonas aeruginosa virulence.
AID770028Agonist activity at Pseudomonas aeruginosa PA14 PqsR expressed in Eschericia coli DH5-alpha at 100 uM by beta-galactosidase reporter gene assay relative to PQS2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Discovery and biophysical characterization of 2-amino-oxadiazoles as novel antagonists of PqsR, an important regulator of Pseudomonas aeruginosa virulence.
AID770032Binding affinity to Pseudomonas aeruginosa PA14 biotinylated His6SUMO-tagged PqsR expressed in Eschericia coli BL21 (DE3) by surface plasmon resonance spectroscopic analysis2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Discovery and biophysical characterization of 2-amino-oxadiazoles as novel antagonists of PqsR, an important regulator of Pseudomonas aeruginosa virulence.
AID770030Competitive binding affinity to Pseudomonas aeruginosa PA14 biotinylated His6SUMO-tagged PqsR expressed in Eschericia coli BL21 (DE3) at 1 to 81 uM by surface plasmon resonance spectroscopic analysis in presence of PQS2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Discovery and biophysical characterization of 2-amino-oxadiazoles as novel antagonists of PqsR, an important regulator of Pseudomonas aeruginosa virulence.
AID7180Percent inhibition against RBL-1 5-LO in vitro at 300 uM1987Journal of medicinal chemistry, Mar, Volume: 30, Issue:3
Hydroxamic acid inhibitors of 5-lipoxygenase.
AID770029Binding affinity to Pseudomonas aeruginosa PA14 biotinylated His6SUMO-tagged PqsR expressed in Eschericia coli BL21 (lamda DE3) by isothermal titration calorimetry2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Discovery and biophysical characterization of 2-amino-oxadiazoles as novel antagonists of PqsR, an important regulator of Pseudomonas aeruginosa virulence.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (30.56)18.7374
1990's5 (13.89)18.2507
2000's1 (2.78)29.6817
2010's17 (47.22)24.3611
2020's2 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.45 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index6.09 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.78%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (97.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]